---
title: "CYTK SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Cytokinetics (CYTK), with links to the SEC filings."
url: "https://tradytics.com/research/CYTK/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=CYTK&v=stock-11994868"
---

# CYTK financial statements and SEC filings

## CYTK annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $88.04M | -$612.26M | -$784.96M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm) |
| 2024-12-31 | $18.47M | -$536.25M | -$589.53M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm) |
| 2023-12-31 | $7.53M | -$496.20M | -$526.24M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm) |
| 2022-12-31 | $94.59M | -$324.20M | -$388.95M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017025029206/0000950170-25-029206-index.htm) |
| 2021-12-31 | $70.43M | -$186.31M | -$215.31M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017024022256/0000950170-24-022256-index.htm) |
| 2020-12-31 | $55.83M | -$93.94M | -$127.29M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017023005515/0000950170-23-005515-index.htm) |

## CYTK annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $1.42B | $2.08B | -$659.62M | [10-Q](https://www.sec.gov/Archives/edgar/data/1061983/000119312526447408/0001193125-26-447408-index.htm) |
| 2024-12-31 | $1.40B | $1.54B | -$135.37M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm) |
| 2023-12-31 | $824.32M | $1.21B | -$386.32M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017025029206/0000950170-25-029206-index.htm) |
| 2022-12-31 | $1.01B | $1.12B | -$107.90M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017024022256/0000950170-24-022256-index.htm) |
| 2021-12-31 | $841.32M | $597.46M | $243.86M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017023005515/0000950170-23-005515-index.htm) |
| 2020-12-31 | $533.80M | $420.42M | $113.38M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000156459022007218/0001564590-22-007218-index.htm) |

## CYTK annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$510.01M | -$24.81M | $524.46M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm) |
| 2024-12-31 | -$395.89M | -$3.91M | $930.61M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm) |
| 2023-12-31 | -$414.33M | -$1.42M | $221.32M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm) |
| 2022-12-31 | -$299.52M | -$11.34M | $516.17M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017025029206/0000950170-25-029206-index.htm) |
| 2021-12-31 | -$142.52M | -$48.87M | $319.98M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017024022256/0000950170-24-022256-index.htm) |
| 2020-12-31 | $8.94M | -$11.05M | $234.12M | [10-K](https://www.sec.gov/Archives/edgar/data/1061983/000095017023005515/0000950170-23-005515-index.htm) |

- [CYTK stock research](https://tradytics.com/research/CYTK)
- [CYTK financial summary](https://tradytics.com/research/CYTK/financials)
- [Read the data without JavaScript](https://tradytics.com/research/CYTK/fundamentals?snapshot=1)
